Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging.

Autor: Linda G Rikkert, Leonie de Rond, Annemieke van Dam, Ton G van Leeuwen, Frank A W Coumans, Theo M de Reijke, Leon W M M Terstappen, Rienk Nieuwland

Publikováno v: PLoS ONE, Vol 15, Iss 6, p e0233443 (2020)

Large (> 1 μm) tumor-derived extracellular vesicles (tdEVs) enriched from the cell fraction of centrifuged whole blood are prognostic in metastatic castration-resistant prostate cancer (mCRPC) patients. However, the highest concentration of tdEVs is

Externí odkaz: https://doaj.org/article/0e62668cfaef4da3aacd2e07deabb1d9

A Cluster-Randomized Trial of Two Strategies to Improve Antibiotic Use for Patients with a Complicated Urinary Tract Infection.

Autor: Veroniek Spoorenberg, Marlies E J L Hulscher, Ronald B Geskus, Theo M de Reijke, Brent C Opmeer, Jan M Prins, Suzanne E Geerlings

Publikováno v: PLoS ONE, Vol 10, Iss 12, p e0142672 (2015)

Up to 50% of hospital antibiotic use is inappropriate and therefore improvement strategies are urgently needed. We compared the effectiveness of two strategies to improve the quality of antibiotic use in patients with a complicated urinary tract infe

Externí odkaz: https://doaj.org/article/880cadce80c249609ce718d83db10dbf

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study

Autor: Bart Geboers, William Gondoputro, James E. Thompson, Daan J. Reesink, Luigi A.M.J.G. van Riel, David Zhang, Alexandar Blazevski, Paul Doan, Shikha Agrawal, Jayne Matthews, Anne-Maree Haynes, Zhixin Liu, Warrick Delprado, Ron Shnier, Theo M. de Reijke, Nathan Lawrentschuk, Pascal E.F. Stijns, John W. Yaxley, Matthijs J. Scheltema, Phillip D. Stricker

Publikováno v: European urology focus, 8(6), 1591-1598. Elsevier BV

Background: Accurate monitoring following focal treatment of prostate cancer (PCa) is paramount for timely salvage treatment or retreatment. Objective: To evaluate the diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) to detec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc07c18711e27c634891644c05fa48f
https://doi.org/10.1016/j.euf.2022.04.010

Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences

Autor: Matthijs J. Scheltema, Tim J. O’Brien, Willemien van den Bos, Daniel M. de Bruin, Rafael V. Davalos, Cees W.M. van den Geld, Maria P. Laguna, Robert E. Neal, Ioannis M. Varkarakis, Andreas Skolarikos, Phillip D. Stricker, Theo. M. de Reijke, Christopher B. Arena, Jean de la Rosette

Publikováno v: Therapeutic Advances in Urology, Vol 11 (2019)

Background: At present, it is not possible to predict the ablation zone volume following irreversible electroporation (IRE) for prostate cancer (PCa). This study aimed to determine the necessary electrical field threshold to ablate human prostate tis

Externí odkaz: https://doaj.org/article/4f38682998da4f38bedccfc4d8a2910e

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice

Autor: Ben-Max de Ruiter, Maaike W. van de Kamp, Jonah P.Z. van Steenbergen, Martine Franckena, Joost L. Boormans, Jeantine M. de Feijter, Adriaan D. Bins, Maarten C.C.M. Hulshof, Theo M. de Reijke, Eva Schaake, Jorg R. Oddens

Publikováno v: European Urology Open Science, 39, 7-13. Elsevier BV
European Urology Open Science, 39, 7-13. Elsevier
de Ruiter, B-M, van de Kamp, M W, van Steenbergen, J P Z, Franckena, M, Boormans, J L, de Feijter, J M, Bins, A D, Hulshof, M C C M, de Reijke, T M, Schaake, E & Oddens, J R 2022, ' A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice ', European Urology Open Science, vol. 39, pp. 7-13 . https://doi.org/10.1016/j.euros.2022.02.010

Background: Concurrent chemoradiotherapy (CRT) as a definitive treatment option for patients with nonmetastatic muscle-invasive bladder carcinoma (MIBC) is increasingly being applied in clinical practice. Objective: To assess the oncological and toxi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d17d3d255591b28de94b2782f836ae4d
http://www.scopus.com/inward/record.url?scp=85126460889&partnerID=8YFLogxK